SCHEMBL15701288

SCHEMBL15701288

N#Cc1cccc(C(=O)Nc2ccc3nc(NC(=O)c4cscn4)sc3c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 1/20 0.48
HSD17B2 P37059 1/20 0.48
SNCA P37840 1/20 0.48
SCD O00767 1/20 0.48
MAPT P10636 5/20 0.47
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
ALDH1A1 P00352 2/20 0.47
DYRK1A Q13627 2/20 0.47
CASP3 P42574 3/20 0.46
SENP8 Q96LD8 3/20 0.46
SENP7 Q9BQF6 3/20 0.46
SENP6 Q9GZR1 3/20 0.46
POLB P06746 3/20 0.46
GRM4 Q14833 1/20 0.45
PDE10A Q9Y233 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
TDP1 Q9NUW8 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15701155 0.87 MEN1 (0.59) HSD17B1HSD17B2SNCASCDMAPT
SCHEMBL15701156 0.86 RIPK1 (0.49) MAPTNPC1RAB9ADYRK1ACASP3
SCHEMBL15701230 0.86 DYRK2 (0.50) MAPTRAB9AALDH1A1DYRK1APOLB
SCHEMBL15701119 0.86 SCD (0.61) HSD17B1HSD17B2SNCASCDMAPT
SCHEMBL15701242 0.85 SCD (0.68) SCDMAPTNPC1RAB9AALDH1A1
SCHEMBL15701145 0.85 PSEN1 (0.46) MAPTNPC1RAB9AALDH1A1DYRK1A
SCHEMBL15701152 0.84 FFAR2 (0.44) MAPTNPC1RAB9AALDH1A1DYRK1A
SCHEMBL15701137 0.84 DHODH (0.52) HSD17B1HSD17B2SNCAMAPTNPC1
SCHEMBL15701257 0.84 DHODH (0.52) HSD17B1HSD17B2SNCAMAPTNPC1
SCHEMBL6229783 0.80 RAB9A (0.62) HSD17B1HSD17B2SCDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2914592-B1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INT (DE) 2017-10-11 EP disclosed
US-9334249-B2 Inhibitors of cytomegalovirus BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-05-10 US disclosed
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-08 US disclosed
WO-2014070979-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS CDKN1A, CCNA1, IFNAR1 HSD17B1 1374/4885HSD17B2 2619/4885SNCA 3918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.